Bristol-Myers Squibb Co (BMY)
57.58
+0.25
(+0.44%)
USD |
NYSE |
Dec 23, 16:00
57.47
-0.11
(-0.19%)
Pre-Market: 08:38
Bristol-Myers Squibb Free Cash Flow: 13.80B for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Amgen Inc | 6.283B |
| Johnson & Johnson | 19.02B |
| Eli Lilly and Co | -2.275B |
| Merck & Co Inc | 14.84B |
| Pfizer Inc | 8.227B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 5.591B |
| Cash from Investing (Quarterly) | -219.00M |
| Cash from Financing (Quarterly) | -3.852B |
| Free Cash Flow Per Share (Quarterly) | 2.593 |
| Free Cash Flow to Equity (Quarterly) | 7.904B |
| Free Cash Flow to Firm (Quarterly) | 5.633B |
| Free Cash Flow Yield | 11.81% |